DJIA 16,654.77 369.26 2.27%
NASDAQ 4,812.71 115.17 2.45%
S&P 500 1,987.66 47.15 2.43%
market minute promo

Pfizer (NYSE: PFE)

33.26 0.83 (2.56%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $33.26 2.56%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.78
Previous Close $32.43
Daily Range $32.67 - $33.62
52-Week Range $27.51 - $36.46
Market Cap $205.1B
P/E Ratio 23.00
Dividend (Yield) $1.12 (3.5%)
Ex-Dividend Date
Dividend Pay Date
08/05/15
09/02/15
Volume 38,514,687
Average Daily Volume 24,076,759
Current FY EPS $2.06

Sector

Healthcare

Industry

Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary Rss Feed

GlaxoSmithKline: Buy or Bye?

With all the recent news, is the London-based pharmaceutical giant a buy now?

JNJ’s Splenda Sale Shouldn’t Be A Concern For Investors

Deutsche Bank Says Stick With Top Stocks Growing Dividends

The Zacks Analyst Blog Highlights: Skyworks Solutions, United Online, National Commerce, Hospira and

The Zacks Analyst Blog Highlights: Skyworks Solutions, United Online, National Commerce, Hospira and Pfizer

Pfizer Nears Completion of Hospira Acquisition

Short Sellers Have Mixed Feelings on Major Pharma

Alliance Foundation Trials and Austrian Breast & Colorectal Cancer Study Group Open Largest Global P

Alliance Foundation Trials and Austrian Breast & Colorectal Cancer Study Group Open Largest Global Phase 3 Trial of Targeted Therapy, IBRANCE, for Patients with Hormone Receptor–Positive Early Breast Cancer

Alvogen to Acquire Product Portfolio from Pfizer for the U.S. Market, no terms

AstraZeneca: A High-Yield Play In The Burgeoning Oncology Field

These 4 Resilient Stocks Survived Monday's Selloff

Company News for August 25, 2015

See More PFE News...

PFE's Top Competitors

PFE $33.26 (2.56%)
Current stock: PFE
ROG $53.95 (1.22%)
Current stock: ROG
MRK $54.95 (0.97%)
Current stock: MRK
GSK $41.21 (1.83%)
Current stock: GSK